PT-141

PT-141 is chosen for two situations. The first is AAS-related libido suppression where testosterone levels may still be present but the central drive is blunted. The second is a straightforward desire for reliable libido and sexual performance enhancement on demand. Women also use it for HSDD, which makes this compound unusual in being meaningfully used across genders.

• Reconstitute with bacteriostatic water (1–2 mL per vial) and store refrigerated.
• Inject subcutaneously into abdominal fat 45 minutes to 2 hours before intended use.
• Begin with a low dose (0.5–1 mg) and assess nausea response before increasing. Many users find 1–1.5 mg is sufficient.
• Nausea is dose-dependent and is the primary reason users reduce dose rather than increase. Taking it with a small amount of food reduces nausea without meaningfully blunting the effect.
• Not intended for daily use. Use it as needed.

It works acutely, typically within 45–90 minutes of injection. The effect duration is 6–12 hours for most users. Nausea peaks within the first 1–2 hours and usually subsides on its own.

Use context

PT-141’s appeal in performance circles is specific. AAS use reliably suppresses natural testosterone and can dramatically reduce libido and sexual function even when performance remains good. PT-141 addresses this from a completely different angle than testosterone restoration. It acts centrally on the brain’s sexual response circuitry rather than through peripheral hormone levels.

This makes it uniquely useful during and after cycles where libido loss is a quality-of-life issue but where full hormonal normalization takes time. It is also used simply because it works, often better than PDE5 inhibitors for desire rather than just mechanical function.

Starting too high and creating a nausea-dominated experience that puts users off a compound that actually works well at lower doses. Using it daily rather than as needed and accumulating unnecessary side effect burden. Assuming the dose that causes the most flushing is the most effective.

Compared with Melanotan II, PT-141 is the active fragment responsible for the sexual effects without the prolonged tanning. Compared with PDE5 inhibitors, it addresses desire and central drive rather than just the vascular mechanics of erection.